FDAnews Announces: FDA Ad and Promo Enforcement Trends Webinar on July 13, 2022

Share Article

Drug professionals see what promotional communications stand up to new FDA scrutiny? Here’s how to stay compliant.

FDA Ad and Promo Enforcement Trends
Past, Present and Future
Wednesday, July 13, 2022, 1:30 p.m.–3:00 p.m. EDT
https://wcg.swoogo.com/fda-ad-and-promo-enforcement-trends

What drugmakers don’t know about the FDA’s Office of Prescription Drug Promotion’s (OPDP) enforcement trends can hurt them.

With the agency’s priorities changing, and its associated accelerated use of untitled and warning letters, drugmakers need to take steps now to ensure their ads and promos comply. This webinar will show them how.

Mark Senak, senior vice president and partner at FleishmanHillard, has a unique background that blends expertise in law, communications, public health and public relations. He’ll walk attendees through what’s needed to understand and do to avoid OPDP enforcement action, sharing the latest trends and FDA research to understand the most frequent mistakes and avoid the greatest risks.

He’ll also share the issues that have tripped up other drugmakers and the types of communications vehicles that will put professionals in the crosshairs of enforcement action, along with:

  • The most common ad and promo violations that trigger regulatory action by the FDA
  • The most recent trends with respect to enforcement and different types of promotional communications, especially in response to direct-to-consumer (DTC) promotions
  • How digital and social promotional communications have impacted enforcement, including via Twitter and Facebook
  • The most frequently cited violations by OPDP, including the uptick in preapproval promotion, and how these have changed over the years
  • How current OPDP research might impact future enforcement, such as communicating about products that have Accelerated Approval

Drugmakers can avoid OPDP enforcement action by identifying and getting ahead of the hazards. This webinar will provide the answers.

Webinar Details
FDA Ad and Promo Enforcement Trends
Past, Present and Future
Wednesday, July 13, 2022, 1:30 p.m.–3:00 p.m. EDT
https://wcg.swoogo.com/fda-ad-and-promo-enforcement-trends

Tuition:
$287

Easy Ways to Order:
Online: https://wcg.swoogo.com/fda-ad-and-promo-enforcement-trends
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDAnews
703-538-7665
Email >
Visit website